Drug Discovery News

Scientists engaging + enlightening Scientists

Drug Discovery News (DDN) is the latest addition to LabX Media’s Science Technology Group.

DDN provides engaging stories about scientific breakthroughs to help life science researchers develop diagnostic and therapeutic approaches for improving human health.

Exploring Drug Discovery and Development

DDN brings together a large group of decision makers from pharma, biotech, non-profit, academic, clinical, and government labs. Our readers span research fields from analytical chemistry to toxicology, and from basic through translational, preclinical, and clinical research stages.

  • 34,000+

    Print subscribers

  • 60%

    Of the audience works in commercial or clinical labs

  • 66,000

    Newsletter subscribers

  • 65,900

    3rd party subscribers

  • 86%

    Of DDN subscribers are involved in the purchasing decisions for lab products and analytical instruments

Team Up With Drug Discovery News

Our editorial and content creation teams are made up of scientists, so we know how your customers think and what they need. We will partner with you to bring your message directly to our broad audience of basic, translational, preclinical, and clinical research scientists.

See more of Drug Discovery News, get a current Media Kit, and connect with us today.

Let us help you create your own custom content to reach our audience.